Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Inc. (ERNA) Stock Ticker

NASDAQ: ERNA · Healthcare · Biotechnology
$3.45-4.83%
USD · as of 2026-09-27 · market cap $1.1M
Open ERNA in TickrDownload for iPhone

ERNA right now

Growing revenue 230% a year on 81% gross margins.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full ERNA picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on ERNA
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory cytokines, namely IL-7 and IL-15, intended for the treatment of ovarian cancer. Additionally, Ernexa is developing ERNA-102, an iMSC product engineered to secrete the anti-inflammatory cytokine IL-10, aimed at managing rheumatoid arthritis. The company has a licensing arrangement in place with Factor Bioscience Limited. Established in 2018, this Cambridge, Massachusetts-based entity operated as Eterna Therapeutics Inc. until its rebranding to Ernexa Therapeutics in March 2025.

ERNA stock facts

Ticker symbolERNA
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$1.1M
CEOSanjeev Luther
Employees5
HeadquartersCambridge, MA, US
IPO date1991-08-29
Websitewww.ernexatx.com

What you can see for ERNA on Tickr

Live ERNA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ERNA report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Ernexa Therapeutics Inc.?

The ticker symbol for Ernexa Therapeutics Inc. is ERNA, listed on the NASDAQ Global Market.

What is ERNA?

Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory…

HomeExploreMarketLists
All pages